QIMR Berghofer is one of Australia’s most successful medical research institutes. The Institute was established 70 years ago by the Queensland Government and has a rich history of scientific discoveries and translational medical research.

QIMR Berghofer is focused on improving health by developing new diagnostics, better treatments and prevention strategies, specifically in the areas of cancer, infectious diseases, mental health and complex disorders.

Working in close collaboration with clinicians and other research institutes, QIMR Berghofer is home to more than 600 scientists, students and support staff.

The Institute has an active program for the patenting and commercialisation of technologies, including those developed in conjunction with academic or commercial collaborators.

QIMR Berghofer also has facilities for the GMP manufacture of cell-based and molecular therapies, namely Q-Gen Cell Therapeutics. Also co-located within the Institute is a commercial Phase I/II clinical trials facility, Q-Pharm Pty Ltd, allowing QIMR Berghofer scientists and external clients the extended and unique capability for taking research findings from the laboratory bench to the hospital bedside.